ATI heads into its Q1 2026 print with options traders unusually tilted toward calls — a sharp contrast to the broader caution gripping aerospace and defense names this week.
The bullish skew in options is the most distinctive signal heading into the report. The put/call ratio has dropped to 0.39, more than 1.4 standard deviations below its 20-day average of 0.45, meaning call activity is running well ahead of puts relative to recent norms. That's the most call-heavy reading in weeks. It comes despite ATI slipping 3.6% on Tuesday to $146.23 — pulling it down 4.6% on the week — and most correlated peers also trading lower. HWM lost 2.9% on the week, CRS fell 2.4%, and WWD dropped 4.3%. The options skew suggests a subset of investors is looking through the near-term weakness.
Short interest does nothing to complicate the bullish read. At 2.8% of the free float, it is modest by any measure. That position has actually shrunk 2.2% over the past week, after having built up through mid-April. Borrow conditions are correspondingly loose — availability is wide, and the cost to borrow is running at just 0.51% annualised. That cost has risen sharply over a month (up roughly 73%), but the absolute level remains negligible. There is no meaningful squeeze dynamic in play.
The analyst community has been constructive and growing more so. Wells Fargo initiated coverage at Overweight with a $175 target on April 1, followed by Susquehanna lifting its target to $185 and Keybanc raising to $167, both on April 9-10. The consensus mean target of $173 implies roughly 18% upside from the current price — a healthy premium that reflects the Street's view on ATI's positioning in aerospace, defense, and specialty energy. EPS momentum ranks in the 80th percentile on a 90-day basis, and forward EPS estimates are rising year-over-year at a 73rd-percentile pace. The analyst recommendation divergence score sits at the 93rd percentile — meaning ATI's consensus is meaningfully more bullish than the broader universe. Bears focus on weakness in non-A&D end markets: electronics, medical, and industrial sales have lagged, and the valuation on EV/EBIT remains compressed versus peers like CRS.
Insiders have been net sellers in recent months. Executive Chairman Robert Wetherbee sold over $8.7m worth of shares across four transactions on February 17, and an SVP added a further $505k sale in March. That selling followed stock awards in January, so some dilution offsets apply, but the net direction through Q1 was clearly outward. This is context worth holding alongside the bullish options and analyst activity — the people closest to the business were trimming, not adding.
The Q1 print will test whether ATI's Specialty Energy segment — the bull case's centrepiece — can sustain the mid-teens growth rate projected for 2026, and whether margin expansion continued even as non-A&D volumes remained soft.
See the live data behind this article on ORTEX.
Open ATI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
